Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk ...

A new preclinical study unveils a more powerful and effective immunotherapy for bladder cancer and other solid tumours.

A comprehensive carcinogenicity study on the world's most used herbicide, glyphosate, involving scientists from Europe and ...

The median time to treatment initiation is increasing across cancer types, and this appears to be driven by an increase in stage I cancer diagnoses, data suggest.

Donald A. Newell passed away peacefully on the afternoon of June 22nd,2025 after facing metastatic bladder cancer with ...

In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.

CG Oncology, Inc.'s promising bladder cancer therapy, strong financials, and unique therapeutic profile make it a compelling ...

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a kidney and bladder cancers poster ...

Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...

Why cancer rates are rising in young women—and what to do about it. ... bladder, and skin cancer, laws already limit Americans’ exposure to these pollutants. ...

Bladder cancer is the most common malignancy involving the urinary system and the fifth most prevalent solid tumor in the USA. It accounts for 4.5% of all cancers, ...